CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

Phase 3Cadonilimabcadonilimab
Related Companies

Read the original article

Published by PR Newswire Biotech on October 10, 2026 4:41 AM

Read Original